Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Celldex Therapeutics, Inc. | a2226904zex-32.htm |
| EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc. | a2226904zex-31_1.htm |
| EX-21.1 - EX-21.1 - Celldex Therapeutics, Inc. | a2226904zex-21_1.htm |
| EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc. | a2226904zex-31_2.htm |
| EX-10.4 - EX-10.4 - Celldex Therapeutics, Inc. | a2226904zex-10_4.htm |
| EX-10.12 - EX-10.12 - Celldex Therapeutics, Inc. | a2226904zex-10_12.htm |
| 10-K - 10-K - Celldex Therapeutics, Inc. | a2226904z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (Nos. 333-205694, 333-182142, 333-189336, 333- 151728 and 333-117602) and on Form S-3 (No. 333-192640) of Celldex Therapeutics, Inc. of our report dated February 25, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston,
Massachusetts
February 25, 2016
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM